Study on QOL by severity in patients with atopic dermatitis

Study on QOL by severity in patients with atopic dermatitis - Cross-sectional study using claim data and patient questionnaire on health insurer - Study on QOL by severity in patients with atopic dermatitis - Cross-sectional study using claim data and patient questionnaire on health insurer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051591

Enrollment

1000

Registered

2023-08-01

Start date

2023-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Insured individuals aged equal to or older than 19 years or their dependents who have the data of questionnaire implemented by DeSC as of October 2022 through the health promotion support app "kencom"

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
DLQI EQ-5D-5L	—

Secondary

Measure	Time frame
Actual treatment situation and treatment adherence status TOPICOP WPAI:GH Sleep disturbances NRS Habitual scratching behavior Disease history CDLQI	—

Countries

Japan

Contacts

Public ContactMiyuki Matsukawa

Otsuka Pharmaceutical Co., Ltd. Medical Affairs

Matsukawa.Miyuki@otsuka.jp06-6943-7722

Outcome results